Eosinophils and severe forms of graft-versus-host disease [5]

Blood

Volumn 101, Issue 5, 2003, Pages 2073-2074

  Janin, Anne ^a   Ertault Daneshpouy, Marjan ^b   Socié, Gérard ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

BONE MARROW; BONE MARROW BIOPSY; CELL DENSITY; CLINICAL FEATURE; CLINICAL TRIAL; CONJUNCTIVA; CORRELATION ANALYSIS; DISEASE SEVERITY; EOSINOPHIL; ETHICS; FASCIITIS; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STEROID THERAPY; SYNDROME DELINEATION; UPPER GASTROINTESTINAL TRACT; VALIDATION PROCESS;

EID: 0037372444     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-12-3650     Document Type: Letter

References (7)

1. Basara N, Kiehl MG, Fauser AA. Eosinophilia indicates the evolution to acute graft-versus-host disease [letter]. Blood. 2002;100:3055.
2. Daneshpouy M, Socie G, Lemann M, et al. Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host disease. Blood. 2002;99:3033-3040.
3. Rumi C, Rutella S, Bonini S, et al. Immunophenotypic profile of peripheral blood eosinophils in acute graft-vs-host disease. Exp Hematol. 1998;26:170-178.
4. Daneshpouy M, Facon T, Jouet JP. Acute flare-up of conjunctival graft-versus-host disease with eosinophil infiltration in a patient with chronic graft-versus-host disease. Leukemia and Lymphoma. 2002;43:445-446.
5. Desreumaux P, Janin A, Dubucquoi S, et al. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood. 1995;82:1553-1560.
6. Janin A, Socié G, Devergie A, et al. Fasciitis in chronic graft-versus-host disease: a clinicopathological study of 14 cases. Ann Int Med. 1994;120:993-998.
7. Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assos Am Physicians. 1975;88:70-86.